XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 16
XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BIKEWA, BILITRY, BINIVTI, FACULOL, and TAVADGE. The owner is based in XIAMEN.
UNIT 6 OF UNIT 706, 1696 GANGZHONG
ROAD, XIAMEN AREA, CHINA (FUJIAN) PILOT FREETRADE, ZONE
XIAMEN , CN
Showing of trademarks Trademarks
Trademark Classifications
XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. have?
XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.
What trademark classes does XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. file in?
XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.
What are XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD.'s most well-known trademarks?
XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as BIKEWA, BILITRY, BINIVTI, FACULOL, and TAVADGE. These are among 6 currently registered trademarks in the portfolio.
What is XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD.'s trademark registration success rate?
XIAMEN DIKADUO INFORMATION TECHNOLOGY CO., LTD. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.